Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
- Authors:
- Silva, Mariângela de Oliveira
- Castro-Amarante, Maria Fernanda
- Carvalho, Alexia Adrianne Venceslau Brito
- Almeida, Bianca da Silva
- Daher, Isabela Pazotti
- Souza-Silva, Guilherme Antonio de
- Yamamoto, Marcio Massao
- Koike, Gabriela
- Souza, Edmarcia Elisa de
- Wrenger, Carsten
- Ferreira, Luis Carlos de Souza
- Boscardin, Silvia Beatriz
- Silva, Mariângela de Oliveira
- USP affiliated authors: YAMAMOTO, MARCIO MASSAO - ICB ; WRENGER, CARSTEN - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; BOSCARDIN, SILVIA BEATRIZ - ICB ; SILVA, MARIÂNGELA DE OLIVEIRA - ICB ; AMARANTE, MARIA FERNANDA DE CASTRO - ICB ; CARVALHO, ALEXIA ADRIANNE VENCESLAU BRITO - ICB ; ALMEIDA, BIANCA DA SILVA - ICB ; DAHER, ISABELA PAZOTTI - FM ; SILVA, GUILHERME ANTONIO DE SOUZA - ICB ; KOIKE, GABRIELA - ICB ; SOUZA, EDMARCIA ELISA DE - ICB
- Unidades: ICB; FM
- DOI: 10.3390/vaccines12040356
- Subjects: PARASITOLOGIA; MICROBIOLOGIA; PROTEÍNAS RECOMBINANTES; PROTEÍNAS SANGUÍNEAS; ANTICORPOS; IMUNOGENICIDADE DA VACINA; IMUNOGENÉTICA; IMUNOGLOBULINAS; COVID-19; VACINAS VIRAIS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 09 jul. 2025. -
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356 -
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2025 jul. 09 ] Available from: https://doi.org/10.3390/vaccines12040356 -
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2025 jul. 09 ] Available from: https://doi.org/10.3390/vaccines12040356 - A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
- Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation
- Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines
- Reactivity of DENV-positive sera against recombinant envelope proteins produced in bacteria and eukaryotic cells
- Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen
- Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin
- STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells
- Type 1 and 2 mouse spleen conventional dendritic cells differentially prime T helper cells after antigen targeting via DEC205 and DCIR2 receptors
- Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells
Informações sobre o DOI: 10.3390/vaccines12040356 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
